Pfizer To Present New Data In Advanced Kidney, Lung And Hematologic Cancers At ... 
FiercePharma
New data will be presented on targeted cancer treatments from the Pfizer Oncology portfolio across three key therapeutic categories, including tumors of the kidney, lung and hematologic malignancies, at the Annual Meeting of the American Society of ...
New cancer research data to be presented by Pfizer CSL Recruitment

all 63 news articles » 

Gamida Cell Raises $10M to Progress Phase III-Stage Hematologic Cancer Cell ... 
Genetic Engineering News
The NAM technology also forms the basis of the firm's CordBridge? candidate for treating neutropenia, and is being applied to natural killer cell expansion to develop products for solid and hematological cancers, and to mesenchymal stem cells for ...

and more » 

Positive Phase 2 Clinical Data with Tivantinib in Hepatocellular Carcinoma to ... 
MarketWatch (press release)
Adverse events were reported at similar rates in the treatment and placebo arms, except for a higher incidence of fatigue and hematologic events, including neutropenia and anemia, in tivantinib-treated patients. The incidence of hematologic events ...

and more » 

Analysis of Data from Two Phase 3 Studies Shows DIFICID® Offered Faster ... 
MarketWatch (press release)
Cancer patients also are at risk for CDAD due to prolonged hospitalization and exposure to antibiotics. In fact, cancer patients with solid tumor or hematologic malignancies account for 16% of hospital CDAD cases. The results are based on two ...

and more » 

Epizyme Announces Appointment of Eric Hedrick, MD, as Chief Medical Officer 
MarketWatch (press release)
Dr. Hedrick brings extensive experience in both the development and post-approval clinical management of innovative cancer therapies that target both hematologic malignancies and solid tumors. Eric was most recently at Pharmacyclics as VP of Oncology ...

and more » 

Lenalidomide following stem cell transplant can halt progression of blood cancer 
News-Medical.net
Maziarz serves as medical director of the Adult Stem Cell Transplantation Program & Center for Hematologic Malignancies at the OHSU Knight Cancer Institute. "We know that for at least three years following a transplant that maintenance therapy with ...

and more » 

STAT3 Mutations Linked to Rare Leukemia 
MedPage Today
The study was funded by the Finnish national government, the Academy of Finland, the Finnish Cancer Societies, the Sigrid Juselius Foundation, the Finnish Association of Hematology, the National Clinical Graduate School, the Finnish Funding Agency for ...

and more » 

Revlimid (Lenalidomide) For Myeloma - Phase III Study Findings 
Medical News Today
... (Revlimid) long-term 'maintenance' efficacy for patients with multiple myeloma has demonstrated considerable improvements from the time to progression and overall survival for those suffering from this often-fatal form of hematologic cancer.
Lenalidomide prolongs disease control for multiple myeloma patients after stem ... Medical Xpress

all 4 news articles » 

Hitting The Jackpot With Small Cap Bio Pharma Investment, Part 2: A Threshold ... 
Seeking Alpha
Threshold Pharma focuses on the discovery and development of drugs for the microenvironment of solid tumors and the bone marrows of hematologic malignancies as novel treatments for patients living with cancer. Its clinical development product is TH-302 ...

and more » 

Syndax Pharmaceuticals Appoints Luke Evnin, Ph.D. to Board of Directors 
PR Newswire (press release)
Entinostat has been studied in more than 600 cancer patients with clinical activity in solid tumors and hematologic malignancies. Randomized, placebo-controlled phase 2 studies with entinostat have demonstrated promising results in combination with ...

and more »